News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ipsen (IPN.PA) Announces 16 Abstract Presentations Of Oncology Portfolio At European Society Of Medical Oncology Congress



9/6/2017 11:53:28 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that irinotecan liposome injection (Onivyde®), cabozantinib (Cabometyx®), lanreotide (Somatuline® Autogel® / Depot), telotristat ethyl (Xermelo®) and neuroendocrine tumors are the subject of 16 presentations at the European Society of Medical Oncology (ESMO 2017) congress. The meeting takes place in Madrid (Spain) September 8-12, 2017.


Related News

comments powered by Disqus
Ipsen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES